Intracellular selection of peptide inhibitors that target disulphide-bridged Aβ42 oligomers.
Ontology highlight
ABSTRACT: The β-amyloid (Aβ) peptide aggregates into a number of soluble and insoluble forms, with soluble oligomers thought to be the primary factor implicated in Alzheimer's disease pathology. As a result, a wide range of potential aggregation inhibitors have been developed. However, in addition to problems with solubility and protease susceptibility, many have inadvertently raised the concentration of these soluble neurotoxic species. Sandberg et al. previously reported a β-hairpin stabilized variant of Aβ42 that results from an intramolecular disulphide bridge (A21C/A31C; Aβ42cc), which generates highly toxic oligomeric species incapable of converting into mature fibrils. Using an intracellular protein-fragment complementation (PCA) approach, we have screened peptide libraries using E. coli that
SUBMITTER: Acerra N
PROVIDER: S-EPMC4243997 | biostudies-literature | 2014 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA